Analysts polled by Thomson Reuters were expecting the retail drugstore chain operator to post an increase of 3.8% for last month.
The increase in Walgreen's November numbers was driven by improved pharmacy sales, which increased by 7.6%.
Must Read: Warren Buffett's 25 Favorite Stocks
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Comparable store pharmacy sales grew by 6.7%, while analysts were expecting a 5.3% rise.
For November, the company said its pharmacy sales represented 65.2% of its total sales.
Shares of Walgreens are up 0.82% to $67.30 in pre-market trading today.
Separately, TheStreet Ratings team rates WALGREEN CO as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate WALGREEN CO (WAG) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income."